1-(3-Amino-4-methylphenyl)-9-bromobenzo[h][1,6]naphthyridin-2(1H)-one, 98%, 250mg

3-Bromo-2-chlorobenzaldehyde, 95.0%, 10g

13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 3,10-dicarboxy-14,14-dimethyl-12-oxo-, 1-(1,1-dimethylethyl) ester, [R-(R*,R*)]- 9CI, ?97.0%, 1g

1-(4-Bromo-3-nitrophenyl)ethanone, 95.0%, 25g

9-Hexadecenoic acid, (9E)-, 250mg

2-(5-Nitropyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline, 97.0%, 5g

N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide, 99.0%, 5g

1-Butyl-3-methylimidazolium acetate, 99.0%, 5g

Methyl 3-(4-(aminomethyl)phenyl)propanoate hydrochloride, 95.0%, 1g

Acide orthophosphorique 85%, 85%, Ph.Eur., 1L, emballage plastique.

(s)-2-Amino-2-(4-chloro-3-fluorophenyl)ethan-1-ol, 97%, 1g

4-Cyano-2-(trifluoromethyl)acetanilide, 98.0%, 1g

2-[(1,1-dioxido-1,2-benzisothiazol-3-yl)amino]propanoic acid, 95.0%, 1g